Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial-Reference-Cited by-同舟云学术

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

Published:2009-02 Issue:2 Volume:20 Page:258-264
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Schmidt M.,Victor A.,Bratzel D.,Boehm D.,Cotarelo C.,Lebrecht A.,Siggelkow W.,Hengstler J.G.,Elsäßer A.,Gehrmann M.,Lehr H.-A.,Koelbl H.,von Minckwitz G.,Harbeck N.,Thomssen C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/2/258/391932/mdn590.pdf

Reference28 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2005

2. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007;Goldhirsch;Ann Oncol,2007

3. Side effects of adjuvant treatment of breast cancer;Shapiro;N Engl J Med,2001

4. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study;Ganz;J Natl Cancer Inst,2002

5. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies;Chia;J Clin Oncol,2004

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomics in Clinical trials for Breast Cancer;Briefings in Functional Genomics;2023-12-23

2. Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women With Operable Breast Cancer;JCO Global Oncology;2023-09

3. Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group;Cancers;2023-03-03

4. The evolution of gene expression profiling in breast cancer – A narrative review;Journal of Clinical and Scientific Research;2022-10-04

5. Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer;European Journal of Cancer;2022-09